Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Am J Surg Pathol ; 40(2): 192-201, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26426381

ABSTRACT

Splenic diffuse red pulp small B-cell lymphoma (SDRPL) is considered an indolent neoplasm and its pathogenesis is not well known. We investigated the molecular characteristics of 19 SDRPL patients, 5 of them with progressive disease. IGHV genes were mutated in 9/13 (69%). Cytogenetic and molecular studies identified complex karyotypes in 2 cases, and IGH rearrangements in 3, with PAX5 and potentially TCL1 as partners in each one of them. Copy number arrays showed aberrations in 69% of the tumors, including recurrent losses of 10q23, 14q31-q32, and 17p13 in 3, and 9p21 in 2 cases. Deletion of 7q31.3-q32.3 was present in only 1 case and no trisomies 3 or 18 were detected. NOTCH1 and MAP2K1 were mutated in 2 cases each, whereas BRAF, TP53, and SF3B1 were mutated each in single cases. No mutations were found in NOTCH2 or MYD88. Four of the 5 patients with aggressive disease had mutations in NOTCH1 (2 cases), TP53 (1 case), and MAP2K1 (1 case). The progression-free survival of patients with mutated genes was significantly shorter than in the unmutated (P=0.011). These findings show that SDRPL share some mutated genes but not chromosomal alterations, with other splenic lymphomas, that may confer a more aggressive behavior.


Subject(s)
Biomarkers, Tumor/genetics , Lymphoma, B-Cell/genetics , MAP Kinase Kinase 1/genetics , Mutation , Receptor, Notch1/genetics , Splenic Neoplasms/genetics , Tumor Suppressor Protein p53/genetics , Adult , Aged , Biomarkers, Tumor/analysis , Biopsy , Chile , DNA Copy Number Variations , DNA Mutational Analysis , Disease Progression , Disease-Free Survival , Europe , Female , Gene Deletion , Gene Dosage , Gene Rearrangement , Genes, Immunoglobulin Heavy Chain , Genetic Predisposition to Disease , Humans , Immunohistochemistry , In Situ Hybridization, Fluorescence , Kaplan-Meier Estimate , Lymphoma, B-Cell/chemistry , Lymphoma, B-Cell/pathology , Lymphoma, B-Cell/therapy , Male , Middle Aged , Molecular Diagnostic Techniques , Phenotype , Predictive Value of Tests , Risk Factors , Splenic Neoplasms/chemistry , Splenic Neoplasms/pathology , Splenic Neoplasms/therapy , Time Factors
3.
Histochem Cell Biol ; 130(6): 1155-64, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18769934

ABSTRACT

EMMPRIN has a role in invasion and metastasis through the induction of MMPs and the consequent modulation of cell-substrate and cell-cell adhesion processes. The present study evaluates the expression of EMMPRIN protein and MMP-2/9 activity in tumor and parenchymal cells in a spontaneous metastasis model in rats. Moreover, we explore the regulation of EMMPRIN and MMP-9 by tumor-epithelial cell interactions in vitro. By zymography, we observed an increased proMMP-9 expression in both metastasized liver and spleen samples from tumor bearing rats. Immunohistochemical studies showed EMMPRIN-positive tumor cells in tumor biopsies as well as in spleen and liver samples from tumor bearing rats. Interestingly, a significant increase in EMMPRIN expression in hepatic cells was also detected. The regulation of EMMPRIN expression in tumor and liver cells in response to tumor-host interaction was investigated in vitro through a tumor cell line culture on extracellular matrix (ECM) molecules or in co-culture with normal rat liver cells (BRL3A cells). No significant changes in EMMPRIN expression were detected in tumor cells cultured on ECM molecules. On the other hand, EMMPRIN protein and MMP-9 mRNA expression were induced in BRL3A cells. The increase in EMMPRIN expression in BRL3A cells was inhibited by an anti-EMMPRIN antibody. These results reinforce the main role of EMMPRIN mediating tumor-host interactions that may evolve new opportunities for therapeutic interventions.


Subject(s)
Basigin/metabolism , Fibrosarcoma/enzymology , Liver Neoplasms/enzymology , Mammary Neoplasms, Experimental/enzymology , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/metabolism , Splenic Neoplasms/enzymology , Stromal Cells/enzymology , Animals , Cell Communication , Cell Line, Tumor , Coculture Techniques , Enzyme Precursors/metabolism , Female , Fibrosarcoma/genetics , Fibrosarcoma/pathology , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Neoplastic , Liver Neoplasms/genetics , Liver Neoplasms/secondary , Mammary Neoplasms, Experimental/genetics , Mammary Neoplasms, Experimental/pathology , Matrix Metalloproteinase 2/genetics , Matrix Metalloproteinase 9/genetics , Neoplasm Invasiveness , Neoplasm Metastasis , Rats , Rats, Wistar , Splenic Neoplasms/genetics , Splenic Neoplasms/secondary , Stromal Cells/pathology
4.
Pathol Int ; 56(11): 668-73, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17040289

ABSTRACT

Hepatosplenic gammadelta T-cell lymphoma (HSTL) is a clinicopathological entity associated with an immunocompromised status in approximately 25% of patients. Herein is described a case of HSTL in a 53-year-old Brazilian man with seven previous malaria infections, initially misdiagnosed as a hyperreactive splenomegaly due to chronic malaria. A characteristic lymphoid infiltrate was observed in spleen, liver and bone marrow sinusoids/sinuses. Neoplastic cells had a CD45RO+, CD2+, CD7+, CD3+, CD5-, CD8+, CD56+, perforin+, FasL-negative, T-cell receptor (TCR)alphabeta-negative, TCRgammadelta+ profile. Analyses of gamma and delta TCR rearrangements confirmed diagnosis of gammadelta T-cell lymphoma by detecting VgammaI/Vdelta1-Jdelta1 clonal rearrangements. Sensitive polymerase chain reaction (PCR) for Plasmodium falciparum, Epstein-Barr virus and herpesvirus-8 failed to demonstrate infection. The disease progressed to a fatal outcome following cutaneous infiltration and leukemic proliferation. The authors also comment on the association of lymphoma and infection, focusing on PCR diagnosis of TCRgamma and delta clonal rearrangements and the presumed pathogenic events leading to HSTL in the context of chronic malaria infection. Initial lymphomagenic stages might not be direct consequences of antigenic stimulation of Vdelta1 T-cells, but might depend on interactions between gammadelta T and B cells during cooperative or regulatory responses to Plasmodium sp.


Subject(s)
Liver Neoplasms/pathology , Lymphoma, T-Cell/pathology , Malaria/pathology , Receptors, Antigen, T-Cell, gamma-delta/biosynthesis , Splenic Neoplasms/pathology , DNA, Neoplasm/analysis , Fatal Outcome , Gene Rearrangement, delta-Chain T-Cell Antigen Receptor , Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor , Humans , Immunocompromised Host , Immunophenotyping , Liver Neoplasms/genetics , Liver Neoplasms/immunology , Lymphoma, T-Cell/genetics , Lymphoma, T-Cell/immunology , Malaria/immunology , Male , Middle Aged , Receptors, Antigen, T-Cell, gamma-delta/genetics , Splenic Neoplasms/genetics , Splenic Neoplasms/immunology
SELECTION OF CITATIONS
SEARCH DETAIL